Drug Profile
PU AD companion diagnostic
Alternative Names: PU-AD PET enhancer; PU-AD positron emission tomography enhancer; PU-AD-PETLatest Information Update: 28 Apr 2021
Price :
$50
*
At a glance
- Originator Samus Therapeutics
- Class Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease; Brain injuries
Most Recent Events
- 28 Apr 2021 No recent reports of development identified for preclinical development in Brain injuries in USA
- 28 Apr 2020 No recent reports of development identified for phase-I development in Alzheimer's-disease(Diagnosis) in USA
- 30 Mar 2017 Phase-I clinical trials in Alzheimer's disease (Diagnosis) in USA